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REGULATORY mechanisms in bradykinin (BK) activated
release ofarachidonate (ARA) and synthesis of prostaglan-
din (PG) and platelet activating factor (PAF) were studied
in bovine pulmonary artery endothelial cells (BPAEC). A
role for GTP binding protein (G-protein) in the binding
of BK to the cells was determined. Guanosine 5’-0-
(thiotriphosphate), (GTP:S), lowered the binding affinity
for BK and increased the Kd for the binding from 0.45 to
1.99nM. The Bmax remained unaltered at 2.25 x 10 -11
mole. Exposure of the cells to aluminium fluoride also
reduced the affinity for BK. Bradykinin-induced release of
ARA proved pertussis toxin (PTX) sensitive, with a
maximum sensitivity at 10 ug/ml PTX. GTP,S at 100 #M
increased the release of arachidonate. The effect of GTP,S
and BK was additive at suboptimal doses of BK up to
0.5 nM but never exceeded the levels of maximal BK
stimulation at 50 nM. PTX also inhibited the release of
ARA induced by the calcium ionophore, A23187. Phorbol
12-myristate 13-acetate or more commonly known as
tetradecanoyl phorbol acetate (TPA) itself had little effect
on release by the intact cells. However, at 100nM it
augmented the BK activated release. This was down-
regulated by overnight exposure to TPA and correlated
with down-regulation of protein kinase C (PKC) activity.
The down-regulation only affected the augmentation of
ARA release by TPA but not the original BK activated
release. TPA displayed a similar, but more potent
amplification of PAF synthesis in response to both BK or
the calcium ionophore A23187. These results taken
together point to the participation of G-protein in the
binding ofBK to BPAEC and its activation ofARA release.
Possibly two types of G-protein are involved, one
associated with the receptor, the other activated by Ca2+
and perhaps associated with phospholipase A2 (PLA2). Our
results further suggest that a separate route of activation,
probably also PLA2 related, takes place through a PKC
catalysed phosphorylation.
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Introduction
The exposure of endothelial cells to bradykinin
(BK), a nonapeptide with inflammatory as well as
vasoactive functions, results in the activation of a
number of early metabolic events as determined in
a number of cell types. These events include a
biphasic increase in cytosolic Ca2+,1-4 a transient
membrane hyperpolarization, the activation of
K + channels,
6 formation of diacylglycerol (DAG)
and phosphatidic acid,
7 release of arachidonate
(ARA) from phospholipid stores and synthesis of
prostaglandin (PG) and platelet activating factor
(PAF). Many of these events involve the activation
of phospholipid related hydrolases including
phospholipase A2 (PLA2) and phospholipase C
(PLC).
Whereas the generation of inositol triphosphate
(IP3) and DAG are due to the activation of PLC,
cumulative evidence suggests that the release of free
arachidonic acid from phospholipid stores, at least
in endothelial cells, involves PLA2 activation by
BK.1 Although this release of fatty acid has been
well described, the sequence of events which
follows the binding ofBK to the cell and results in
the activation of PLA2 remains to be fully
elucidated. The resulting increase in cytosolic Ca
2+
is certainly a necessary step. However regulatory
systems such as GTP-binding proteins (G-protein)
and DAG activated protein kinase C (PKC) have
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been implicated in the process. 11’12 In this series of
experiments we attempt to link some of these
second messengers to elucidate the process of
activation of PLA2 by BK in the bovine pulmonary
artery endothelial cell (BPAEC).
Materials and Methods
Cell culture: Endothelial cells were isolated without
the use of proteolytic enzymes. A freshly obtained
calf pulmonary artery was cut open and lightly
scraped with a scalpel. The resulting clumps of
endothelial cells were placed into 35 mm dishes
containing McCoy’s 5A [Sigma, St Louis, MO]
medium supplemented with 20% foetal bovine
serum (FBS) [HyClone, UT].
13
The homogeneity of endothelial cell cultures was
determined morphologically and histochemically.
At confluence the cells displayed a typical
cobblestone appearance and stained positive for
factor VIII antigen according to the method of
Weinberg et al.14 Endothelial cells were maintained
in 25cm
2 flasks containing 6 ml McCoy’s 5A
medium, 20% FBS, 50 #g/ml streptomycin and
50units/ml penicillin. The culture medium was
replaced every 3 days and the cells passaged
biweekly. Cells to be used for experiments were
passaged from 25 cm
2 flasks into 24-well plates,
20 cm
2 dishes or 60 cm
2 dishes at a density of
20 000 cells/cm
2 with trypsin (0.05%). The culture
medium was replaced after 6 days. Two to 3 days
after the last feeding, these cultures were used for
the various experiments.
Release of arachidonate: Confluent cells in 24-well
plates were prelabelled with 3H-arachidonate
[79.9 Ci/mmol, New England Nuclear, MA]
(0.2/tCi per well) for 18 h. They were then washed
once with McCoy’s medium and preincubated for
2 h in McCoy’s medium containing 1% FBS (0.5 ml
per well). This process was found previously to
increase the potential of the cell to synthesize
prostaglandin.
13 In experiments with phorbol ester,
50/al of a 10 x concentration of TPA was added to
the wells during the last 10 min of the preincuba-
tion. Cells were then incubated in McCoy’s medium
containing 2 mg/ml bovine serum albumin (BSA)
(Sigma, St Louis, MO, essentially fatty acid free
from essentially globulin free) and the indicated
additions. After 10 min the medium was removed
and centrifuged (800 g,). Radioactivity was
determined in a 200 #1 aliquot of the supernatant.
Radioimmunoassay (RIA ) for prostaglandins Antibodies
to 6-keto PGFI (6-K-PGFI) were prepared in our
laboratory. PGI2 concentrations were determined as
its stable degradation product 6-K-PGFI. Cross-
reactivity of the antisera against nontargeted PGs
was less than 4%.
11 The radioimmunoassay was
performed as described previously.
13
Platelet activating factor: The synthesis of PAF was
determined as described previously,
is Generally the
procedure of McIntyre et al. was followed.
9
Confluent cells (20 cm
2 Petri dishes) were incubated
with 3H-acetate [3.6 Ci/mmol, New England
Nuclear, Boston, MA] (50 #Ci/dish) in HEPES
buffered Hank’s balanced salt solution [Sigma, St
Louis, MO], pH 7.4, with or without indicated
additions. After 30 min at room temperature, the
incubation was stopped by removing the medium
and adding methanol/water (1:2) containing 50 mM
acetic acid. The cells were scraped into this solution
and transferred to screw-capped tubes containing
chloroform. The plates were washed with methanol
and the wash was added to the screw-capped tubes.
After 2 h at room temperature, chloroform and
water were added to split the monophase. The
chloroform layer was dried under nitrogen and the
lipids redissolved in small amounts of chloro-
form:methanol (2:1). The lipids were separated by
thin layer chromatography (TLC) on alumina
backed silica coated TLC plates in chloro-
form/methanol/acetic acid/water (25:14: 4: 2).
Radioactivity was located by autoradiography and
the radioactive spots were cut from the chromato-
gram and quantitated.
Cellpermeabilization: In order that GTP:S [Boehrin-
ger Mannheim, IN] could penetrate the BPAEC,
the permeability of the cells was increased by a
3 min exposure to saponin (0.02 mg/ml) in McCoy’s
medium at room temperature. The saponin [Sigma,
St Louis, MO] was removed and GTP:S was added
as indicated. This step was followed with vital stain.
Binding ofBK to cells: The binding of BK to cells was
carried out as described previously.
16 Binding was
done in 24-well plates at 4C for 2 h. The cultures
were washed three times with 1 ml of phosphate-
buffered saline (72 mM NaC1, 1.6 mM KC1, 5 mM
NaiHPO4, 0.9mMKH2PO4) at 4C. This was
followed by a 15 min equilibration with 0.5 ml of
modified Hank’s Balanced Salt Solution (HBSS),
pH 7.3, containing 0.05% bovine serum albumin
(BSA), 2 mM bacitracin, 10 mM HEPES, 120 mM
N-methyl-D-glucamine (replacing NaC1), 0.65 mM
CaCl2, 0.25 mM MgC12 and 0.25 mM MgSO4. This
binding medium was removed and replaced with
fresh, chilled binding medium containing the
3H-bradykinin [90 Ci/mmol, Amersham, IL]. Non-
specific binding was determined in the presence of
3/,M unlabelled bradykinin. At the end of the
incubation, the medium was aspirated and the cells
were washed five times with 1 ml of the
Modified Balanced Salt Solution with 0.2% BSA.
This was followed by two washes with 1 ml of
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phosphate-buffered saline. Bound radioactivity was
determined by solubilizing the cells with 0.5 ml
of 0.2% sodium dodecyl sulphate. Radioactivity was
quantitated in New England Nuclear [Boston, MA]
963 using an LKB Rackbeta Counter.
Protein kinase C: To determine PKC activity, cells
were grown to confluence in 60 cm
2 dishes. They
were treated with various effectors and then washed
with cold PBS before harvesting by scraping into
sample buffer (20mM Tris buffer, pH 7.5
containing 0.33 M sucrose, 2 mM EDTA, 0.5 mM
EGTA, and 100/g/ml leupeptin). The scraped cells
were centrifuged at 2 000 x g, and the PKC was
solubilized in 1% Triton x 100 in sample buffer for
30 min on ice. The insoluble material was removed
by centrifugation and the supernatant containing
the PKC was absorbed to DE52 resin. The resin
was then washed with 10 ml sample buyer. PKC
activity was eluted from the resin with sample buffer
containing 100 mM NaC1. Activity was determined
as described by Navarro et al. 17 Aliquots of the
enzyme were mixed with 10 mM MgC12, 100/M
.32p ATP (1 000 dpm/pmol), 50/g of histone III-S
with or without 1 mM CaC12, 5 #g of phosphati-
dylserine, and 20 ng of phorbol dibutyrate (PDBu)
in a final volume of 50/1. Samples were incubated
for 10 min at 30C. The reaction was stopped by
spotting 25/1 of the reaction mixture onto
Whatman 3MM paper and then washing the filter
papers in 10% trichloroacetic acid containing
10 mM sodium pyrophosphate. Protein kinase C
activity was determined by subtracting the amount
of 32p incorporation into histone in the absence of
added Ca2+, phosphatidylserine, and PDBu.
Assay for sn- 1,2-diacylgcerol: Diacylglycerol was
determined according to the method of Preiss et al.18
Cells were grown in 20 cm
2 plates and treated as
indicated in the figure legends. Lipids were
extracted and the dried lipids solubilized in 20/1 of
an octyl-B-D-glycoside/cardiolipin solution (7.5%
octyl-B-D-glycoside, 5 mM cardiolipin in 1 mM
diethylenetriaminepentaacetic acid (DETAPAC)
by sonication in a bath sonicator). Fifty microlitres
reaction buffer (100 mM imidazole HC1, pH 6.6,
100 mM NaC1, 25 mM MgCI2 and 2 mM EGTA),
2/1 100 mM dithiothreitol, 10/1 diluted mem-
branes containing DAG kinase (5/.zg protein) and
8 #1 water were then added. The reaction was
started with the addition of 10/1 10mM
(.2p) ATP prepared in 100 mM imidazole, 1 mM
DETAPAC, pH 6.6. After 30min at 25C the
reaction was stopped with chloroform/methanol
and the lipids extracted. The chloroform layer was
washed twice with 2 ml 1% HC104. The volume of
the chloroform layer was measured and an aliquot
removed and dried under nitrogen for TLC. Silica
Gel 60 thin layer chromatography plates were
activated by running in acetone and air dried
immediately before spotting samples. Plates were
developed with chloroform: methanol:acetic acid
(65:15:5), air dried and spots located by autoradio-
graphy. Radioactivity was quantitated by counting
the scraped silica in a scintillation counter. The
amount of sn.-1,2-DAG present in the original
sample was calculated from the sample volumes and
the specific activity of the ATP.
Results
The effect of GTPS on binding of BK to BPAEC:
To determine interaction between bradykinin,
G-protein and phorbol 12-myristate 13-acetate
(TPA) we first looked at the effect of GTPS on
the binding of BK to endothelial ceils. This was
done in intact cells which were permeabilized with
saponin. A typical binding of BK to endothelial
cells is illustrated as a binding curve (inset) and its
Scatchard plot in Fig. 1. The permeabilization itself
had no effect on the binding. The untreated cells
bound with a Kd of 0.45 nM. Adding GTP:S
(100 #M) to the incubation solution had a marked
negative effect on the binding, increasing the Kd to
1.99nM. Bmax stayed constant as 2.2 x 10-11
mole. GDPflS, structurally similar to GTPS but
not an activator of G-protein, had no effect on
binding (data not shown). In a separate experiment,
aluminium fluoride, which dissociates the G-
protein, reduced the binding of BK significantly as
illustrated in Fig. 2. ATP (10/M) had no effect.
The eect of GTPS on release ofARA: As illustrated
in Fig. 3, the release of arachidonate from
endothelial cells preincubated with H-ARA is
related to the GTP:S concentration up to
approximately 100#M. This release is time
dependent as illustrated in Fig. 4. In this figure the
release of arachidonate by GTP’S (100/M) is
compared to that by BK (50 nM). At 2 min after
addition, BK more than doubles the release of label
while GTP:S has little effect. Some effect by
GTP,S is seen at 5 and 10 min, but this is small
in comparison to BK. At 20 min after stimulation
the effect by GTP:S is 70% that of BK.
The effect of pertussis toxin (PTX) was tested
with regard to the release of arachidonate and PG
synthesis. As illustrated in Fig. 5, PTX had a
negligible inhibition of release by cells not treated
with BK. The release caused by BK (50 nM) was
approximately 12-fold the basal value. PTX reduced
the BK activated increase of arachidonate release to
approximately twice that of the basal value.
Interestingly, PTX also blocked the release caused
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FIG. 1. The binding of BK to BPAEC: effect of GTPS. Confluent cells
were washed and incubated in medium containing 1% FBS for 2 h. They
were permeabilized in McCoy’s medium with saponin (0.02 mg/ml) for
3 min. The cells were incubated in fresh medium with or without GTPS
(100 #M) for 10 min. After this incubation, the cells were rapidly chilled b;
placing on ice and washing with ice cold phosphate buffered saline.
Binding was performed as described in the methods section. Scatchard
plot was generated using the Ligand program. O specific binding (total
binding--nonspecific); specific binding in presence of GTPS.
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FIG. 3. Concentration related effect of GTPS on the release of ARA.
Confluent cells were labelled with 3H-arachidonate for 18 h. Cells were
then washed and incubated in medium containing 1% FBS for 2 h. Cells
were permeabilized by incubation with McCoy’s medium plus saponin
(0.02 mg/ml) for 3 min. The cells were washed and incubated in medium
containing 2 mg/ml BSA and the indicated concentrations of GTPS.
After 15 min medium was removed and arachidonate release determined
as described in the methods section. Results are the mean of
quadruplicate cultures.
by A23187 to a similar degree. The effect was
related to the PTX concentration as illustrated in
Fig. 6. Some effect is seen at 1 ng/ml; by 10 ng/ml
maximum effect is seen. No further inhibition is
detected at 100 ng/ml.
The interaction between BK and GTP:S on the
release of arachidonate is illustrated in Fig. 7.
GTPq:S alone at 100 #M increased release. BK
increased release from 0.5 nM up to 5 nM. At
suboptimal concentrations of BK, the addition of
GTPq:S increased release above that of BK up to
1ooo
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FIG. 2. Effect of aluminum fluoride on BK binding to BPAEC. Confluent
cells were washed and incubated in medium containing 1% FBS for 2 h.
They were then placed on ice and washed with ice-cold phosphate
buffered saline. Sodium fluoride (25mM) and aluminium chloride
(10#M) were added in cold binding buffer containing 3H-bradykinin
(0.5 nM) plus or minus unlabelled bradykinin (3#M). Binding was
determined as described in the methods section.
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0.5nM BK. Above this concentration of BK
GTPS had no additive effect.
Phorbol 12-myristate 13-acetate: Exposure of BPAEC to
TPA (100 nM) for 10 min in absence of BK had no
effect on the release of arachidonate (Fig. 8).
However, as illustrated in the same figure, TPA
increased BK stimulated release. When the cells
were treated overnight with TPA (500 nM) to
down-regulate PKC activity and then were
pretreated with fresh TPA and exposed to BK the
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FIG. 4. Time curve of BK and GTP:S effected release of ARA. Cells were
treated as described in Fig. 3 except that medium was harvested at the
indicated times after bradykinin (50 nM) or GTP,S (100 #M) addition.
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FIG. 5. The effect of PTX on 8K and A2a187 stimulated release of ARA.
Confluent cells were labelled with 3H-arachidonate for 18 h. The cells
were washed and incubated in medium containing 1% FBS with or
without pertussis toxin (10 ng/ml). After 4 h the medium was removed
and medium containing BSA (2 mg/ml) with or without BK (50 nM) or
A23187 (10/M) was added. After 15 min, medium was harvested from
quadruplicate wells and radioactivity determined. Results are the means
of quadruplicate cultures.
[] Cells not treated with PTX
Cells treated with PTX
response to BK remained unaltered, but no
augmentation by TPA was observed (Fig. 8).
Determination ofPKC activity, as illustrated in Fig.
8 (insert) shows that PKC was indeed down-
regulated by exposure of the cells to 500 nM TPA
overnight. In Fig. 9 a similar eect by TPA is seen
in BK activated PAF synthesis. In this case TPA at
16 nM increased BK-activated PAF production by
25
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FIG. 6. Inhibitory effect of PTX at various concentrations. Confluence
cells were washed and incubated in medium containing 1% FBS and the
indicated concentration of pertussis toxin (PTX). After 4 h this medium
was removed and the cells incubated in McCoy’s medium with or without
bradykinin (50 nM) or ionophore A23187 (10/M). After 20 min medium
was harvested from quadruplicate wells and assayed for 6-keto-PGFl
content by RIA.
[--] Control, untreated cells
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FIG. 7. Synergism between BK and GTPS in the release of ARA. Cells
were treated as described in Fig. 3 except that they were incubated with
the indicated concentrations of BK plus or minus GTPS (100/M).
=Only BKat0to50nM
[] BK at 0 to 50 nM + 100#M GTPS
approximately three-fold. Interestingly the response
to A23187, a calcium ionophore, was also
augmented by TPA.
As a further illustration of the participation of
PKC in BK activated release, Fig. 10 shows that in
response to BK, BPAEC produce DAG. D_AG
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FIG. 8. The effect of down-regulation on ARA release by TPA in BK
treated cultures, concomitant down-regulation of PKC. Confluent
cultures were labelled with 3H-arachidonate for 18h. For PKC
down-regulation TPA (500nm) was included during this 18h
incubation. The cells were washed and the medium changed to medium
containing 1% FBS (0.5ml/well). After 2h 50/A of a I#M
solution of TPA was dropped into the appropriate wells. Af,er 10 min the
medium was removed and medium containing 2 mg/ml BSA with or
without BK (50 nM) was added. After 10 min this medium was collected
and arachidonate release determined as described in the methods
section. Results are the means of quadruplicate cultures. Insert: Parallel
cultures were set up in 60 cm Petri dishes. They were treated with the
indicated concentrations of TPA for 18 h. PKC activity was determined
as described in the Methods section.
Cultures not treated with TPA
11 Cultures treated with 100 nM TPA
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FIG. 9. Effect of TPA on BK stimulated PAF synthesis. Confluent cells in
20 cm Petri dishes were treated with the indicated concentrations of TPA
for 10 min. The cells were washed and assayed for PAF production in
response to BK (50 nM) or calcium ionophore (10/M) as described in
the methods section.
production was determined at various concentra-
tions of BK from 0.01 to 50 nM. In this case a
maximum was reached between 0.5 and 2 nM BK.
The interaction of TPA with BK and GTP:S is
illustrated in Fig. 11. The release of arachidonate
was determined with either BK or GTPq:S in the
presence or absence of TPA. In this case TPA
basically doubled the eEect ofBK. It proved to have
no effect on GTP:S stimulated release.
Discussion
In the experiments described we investigated the
high affinity B2 binding site of BK in intact, viable
2000
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1000
500
0 0.005 0.05 0,5 5 50
nM BK
FIG. 10. The synthesis of DAG in the presence of various concentrations
of BK. Confluent cells in 20 cm Petri dishes were incubated with the
indicated concentrations of BK for 10 min. DAG was determined as
described in the methods section.
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FIG. 11. The effect of TPA on GTP,S and BK stimulated release of ARA.
Cells were treated as described in Fig. 9. After the 10 min PMA
incubation, cells were permeabilized with saponin (0.02 mg/ml) for 3 min
and then medium containing 2 mg/ml BSA with or without BK (50 nM)
or GTP,S (100 #M) was added. After 15 min the medium was collected
and 3H-arachidonate release determined as described in the methods
section. Results are the means of quadruplicate cultures.
[] Cultures treated with either (nothing, GTP:S or BK).
Culture treated as above -t- 100 nM TPA.
endothelial cells. We found evidence in these cells
of only one high affinity B2 site.
16 Results illustrated
in Figs 1 and 2 show that this binding of BK
involves G-protein. The addition of GTPq:S, a
non-hydrolysable analogue of GTP, to cells
previously exposed to saponin increased the Kd of
binding by approximately four-fold (0.45 nM to
1.99 nM) while the Brnax remained unchanged at
2.25 x 10-1 mole. This suggests dissociation of
G-protein leading to a lower affinity for BK.
GTPS is known to maintain the G-protein in a
permanently dissociated state. Exposure of the cells
to aluminium fluoride, which dissociates G-protein,
also lowered the binding of BK to the BPAEC.
These experiments, conducted at the cellular level
with the receptor intact, are consistent with reports
using plasma membranes isolated from fractionated
myometrium9’2 and the bovine aorta.
2 Our results
are also consistent with the recent report of the
cloning of the B2 receptor for BK from rat uterus
as a typical G-protein coupled receptor.
22
Separate G-proteins appear to function in the
regulation of PLA2 and PLC. A number of reports
suggest that the generation of inositol triphosphate
(IP3) is not PTX sensitive. In contrast, the action
of PLA2 is PTX sensitive. For example, in 3T3
fibroblasts, thrombin and BK increase Ca2+ influx,
arachidonate release and IP3 release. PTX was
reported to inhibit arachidonate release but not IP
release.
2 In FRTL5 thyroid cells, adrenergic a
receptors are coupled to PLA2 by a PTX sensitive
G-protein, and to PLC by a PTX insensitive
G-protein.
24
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The generation of IP in BPAEC in response to
BK has been shown to be G-protein linked but not
sensitive to PTX.
25 Results here show a clear
inhibition ofARA release by PTX in the same cells.
Our observations further illustrate that PTX
inhibits not only BK-activated release but also
A21387-activated release. This suggests that the
PTX sensitive G-protein may be functioning
beyond the Ca2+ mobilization step. Nakashima
et al. reported previously that N-formyl-methionyl-
leucyl-phenylalanine (fMLP) activated neutrophil
release of arachidonate and PG synthesis.
26 They
also reported that G-protein is involved in this
interaction. They proposed that in the neutrophil
G-protein lowers the requirement of PLA2 for
Ca
2 +.
One explanation for these observations is that the
PTX insensitive G-protein is associated directly
with the BK receptor while the PTX sensitive
G-protein is perhaps associated directly with PLA2.
The G-protein associated with the receptor may be
involved in the BK regulation of cytosolic Ca2+
concentrations. G-protein was recently shown to
participate in the regulation of receptor operated
Ca2+ channels in platelets.
27 Also, a recent report
illustrated that the complex A1F- activated
calcium influx in endothelial cells. 7 The BK receptor
may form a part of a Ca
2+ transporter.
28 The PTX
sensitive G-protein in BPAEC may be one of the
subtypes of Gi. Clark et al.
29 have identified a
41 kDa protein as ADP ribosylated by PTX,
consistent with the molecular weight of Gi. Lee
et al. have demonstrated that endothelial cells
express mRNA for all three subtypes of Gi.
3
Our results illustrate that TPA is also involved
in the release of arachidonate in BPAEC. Generally
phorbol ester has been shown to inhibit the action
of PLC in the generation of IP3 .31 This inhibition
is related to PKC. With regard to the activation of
PLA2 by phorbol ester, the literature is more
tenuous. For example, in the experiments using
MDCK cells,
31 TPA itself stimulated the release of
arachidonic acid which was inhibited by 1-(5-
isoquinolinylsulphonyl)-2-methyl piperazine (H7),
an inhibitor of PKC. In another report using
MDCK cells, the BK response was only slightly
sensitive to PKC inhibitors (sphingosine, H7,
staurosporine).
32 The BK-stimulated release of
arachidonic acid could not be enhanced by TPA in
PKC down-regulated BPAEC. However, in these
cells TPA itself stimulated the release of arach-
idonate which was attenuated (50%) by PKC
inhibitors.
32 Phorbol ester was reported to augment
BK-stimulated PG synthesis in other cell types such
as Swiss 3T3.
33 Other effectors such as thrombin,
which activates PG and PAF synthesis in human
endothelial cells, are augmented by TPA. 34 In the
described experiments, TPA alone did little in the
absence of BK. However, in the presence of BK
the release of arachidonate was synergistic. This
synergism by phorbol was abolished when PKC
was down-regulated by incubating the cells
overnight with TPA. However, the BK-stimulated
release was totally unaffected by the down-
regulation of PKC. This action by TPA appears
related to PLA2. This is suggested in Fig. 9 by the
TPA-augmented, BK-induced synthesis of PAF. In
these experiments the synthesis of PAF was
determined through the remodelling pathway
which utilizes PLA2 to remove fatty acid from the
sn-2 position of 1-O-alkyl-2-acyl-sn-glyceryl-3-phos-
phocholine and incorporates acetate into the
lyso-PAF via lyso-PAF acetyl-CoA acetyltrans-
ferase (LPAT) to form the 1-O-alkyl-2-acetyl-sn-
glyceryl-3-phosphocholine (PAF). It is possible that
TPA in conjunction with BK also activates LPAT.
This is suggested by the considerably larger
augmentation by TPA of BK-stimulated PAF
synthesis than ofARA release. In fact Heller et al.
35
reported recently that thrombin-activated PAF
synthesis in human umbilical vein endothelial cells
involved the activation of LPAT. TPA alone did
not activate LPAT. The effect of thrombin plus
TPA on LPAT activity was not determined.
TPA also did not affect GTPS activation of
release (Fig. 11), suggesting that the two events
represent separate paths to the activation of PEA2.
As we illustrated, BK does generate DAG (Fig.
10), and thus may, under certain conditions,
additionally activate the release of arachidonate
through the action of protein kinase C.
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